GB1075470A - Effervescent tablet - Google Patents

Effervescent tablet

Info

Publication number
GB1075470A
GB1075470A GB2719164A GB2719164A GB1075470A GB 1075470 A GB1075470 A GB 1075470A GB 2719164 A GB2719164 A GB 2719164A GB 2719164 A GB2719164 A GB 2719164A GB 1075470 A GB1075470 A GB 1075470A
Authority
GB
United Kingdom
Prior art keywords
covering layer
core
dye
water
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2719164A
Inventor
James Thomas Rees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Miles Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc
Priority to GB2719164A priority Critical patent/GB1075470A/en
Priority to BE666198A priority patent/BE666198A/xx
Priority to ES0314805A priority patent/ES314805A1/en
Priority to NL6508470A priority patent/NL6508470A/xx
Publication of GB1075470A publication Critical patent/GB1075470A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Effervescent tablets which contain at least one test reagent or diagnostic agent to be dispersed in an aqueous liquid comprise a core and at least one covering layer, each containing a water-soluble dye, the colour produced by the dye in the core on solution in water being different from that produced by the dye in the covering layer(s). The test reagent or diagnostic agent is present in at least the covering layer(s) and the effervescent materials are present in the core and/or covering layer(s).ALSO:Effervescent tablets which contain at least one active agent to be dispersed in an aqueous liquid comprise a core and at least one covering layer, each containing a water-soluble dye, the colour produced by the dye in the core on solution in water being different from that produced by the dye in the covering layer(s). The active agent is present in at least the covering layer(s) and the effervescent materials are present in the core and/or covering layer(s). The active agent may be a therapeutic agent for internal or external use, a laxative, a vitamin preparation, an antacid/analgesic mixture, a stringent, antiseptic, mouth wash, gargle, or dentifrice. A typical example describes a tablet having an inner core of paracetamol, sodium ascorbate, citric acid, NaHCO3, and water-soluble dye and an outer coat of acetylsalicylic acid, citric acid, NaHCO3, and another water-soluble dye.
GB2719164A 1964-07-01 1964-07-01 Effervescent tablet Expired GB1075470A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB2719164A GB1075470A (en) 1964-07-01 1964-07-01 Effervescent tablet
BE666198A BE666198A (en) 1964-07-01 1965-06-30
ES0314805A ES314805A1 (en) 1964-07-01 1965-06-30 Effervescent tablet
NL6508470A NL6508470A (en) 1964-07-01 1965-07-01

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2719164A GB1075470A (en) 1964-07-01 1964-07-01 Effervescent tablet

Publications (1)

Publication Number Publication Date
GB1075470A true GB1075470A (en) 1967-07-12

Family

ID=10255676

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2719164A Expired GB1075470A (en) 1964-07-01 1964-07-01 Effervescent tablet

Country Status (4)

Country Link
BE (1) BE666198A (en)
ES (1) ES314805A1 (en)
GB (1) GB1075470A (en)
NL (1) NL6508470A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092893A1 (en) * 1970-06-29 1972-01-28 Bru Jean
US5015408A (en) * 1988-03-19 1991-05-14 Reckitt Gmbh Denture cleaning tablet containing a bleach activator and an organic phosphonic acid stabilizer
WO2000018370A2 (en) * 1998-09-25 2000-04-06 Delsys Pharmaceutical Corporation Liquid pharmaceutical for oral delivery
WO2000075079A1 (en) * 1999-06-05 2000-12-14 Herbst Juergen Method for dispersing insoluble mineral sediments and additives for carrying out this method

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2074769T3 (en) * 1991-07-01 1995-09-16 Gergely Gerhard PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION WITH AT LEAST TWO DIFFERENT ACTIVE PRINCIPLES AND USE OF A PREPARATION OF THIS TYPE.
DE59308333D1 (en) * 1992-08-06 1998-05-07 Gergely Gerhard Easily consumable effervescent tablet

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092893A1 (en) * 1970-06-29 1972-01-28 Bru Jean
US5015408A (en) * 1988-03-19 1991-05-14 Reckitt Gmbh Denture cleaning tablet containing a bleach activator and an organic phosphonic acid stabilizer
WO2000018370A2 (en) * 1998-09-25 2000-04-06 Delsys Pharmaceutical Corporation Liquid pharmaceutical for oral delivery
WO2000018370A3 (en) * 1998-09-25 2000-07-20 Delsys Pharmaceutical Corp Liquid pharmaceutical for oral delivery
US6616932B2 (en) 1998-09-25 2003-09-09 Delsys Pharmaceutical Corporation Liquid pharmaceutical for oral delivery
WO2000075079A1 (en) * 1999-06-05 2000-12-14 Herbst Juergen Method for dispersing insoluble mineral sediments and additives for carrying out this method

Also Published As

Publication number Publication date
NL6508470A (en) 1966-01-03
ES314805A1 (en) 1966-07-01
BE666198A (en) 1965-12-30

Similar Documents

Publication Publication Date Title
Brand et al. Drugs used in motion sickness. A critical review of the methods available for the study of drugs of potential value in its treatment and of the information which has been derived by these methods
GB1405088A (en) Slow release formulation
AR241676A1 (en) Dosage form comprising fast agent delivery followed by slow agent delivery
NO821832L (en) PROCEDURE FOR THE PREPARATION OF ALLERGIC Capsules
SE7500501L (en)
ES460743A1 (en) Preserving liquid antacid medicinal formulations
GB984464A (en) Therapeutic compositions comprising bromelain
GB1075470A (en) Effervescent tablet
NL149503B (en) PROCESS FOR THE PREPARATION OF A THERAPEUTIC PREPARATION AND A PROCESS FOR THE PREPARATION OF ACTIVE COMPOUNDS TO BE USED THEREIN.
IL39110A (en) Sulphamides,their preparation and pharmaceutical compositions containing them
GB436236A (en) Improvements in and relating to a therapeutic capsule
SE396010B (en) PROCEDURE FOR THE PREPARATION OF ACTIVE SUBSTANCE CONTAINING PREPARATIONS WITH LONG-TERM EFFECT IN THE FORM OF TABLETS, DRAGONS OR CAPSULES
DK122998B (en) Dosage and nebulization bottle for medical use.
BE811397A (en) PREPARATION OF CHEMICAL COMPOSITIONS AND ESPECIALLY OF CHEMICAL COMPOSITIONS DOSE IN THE FORM OF EFFERVESCENT TABLETS
JPS57146722A (en) Pharmaceutical preparation having improved absorption
Hirst Microscopic evaluation of topically applied chlorhexidine gluconate on gingival wound healing in dogs
BE782483A (en) CHOLERETIC MEDICINAL PRODUCTS CONTAINING 1-PHENOXY-3-ALCOXY-PROPANOLS- (2) AS ACTIVE INGREDIENTS AND THE PROCESS OF MANUFACTURING
Segaloff et al. Hormonal therapy in cancer of the breast. XIII. The effect of 9 alpha-fluoro-17 alpha-methyl-delta 4-androsten3-one-11 beta-17 beta-diol (fluoxymetherone) therapy on clinical course and hormonal excretion
GB1327560A (en) Effervescent pharmaceutical preparations
IL37349A (en) Pharmaceutical compositions comprising certain active compounds of acidic character
GB810537A (en) Sweetening composition
GB903162A (en) Kanamycin 3-phenyl salicylate and therapeutic compositions containing it
NL173241C (en) PHARMACEUTICAL PREPARATION IN CAPSULE FORM CONTAINING DANTROLENE.
NO143795C (en) CHEMICAL INTERMEDIATE FOR USE IN THE PREPARATION OF THERAPEUTIC ACTIVE 2,6-METHAN-3-BENZAZOSINES
AR197195A1 (en) AZOIC COLORANT INSOLUBLE IN WATER, PROCEDURE FOR ITS PREPARATION, AND COMPOSITIONS CONTAINING IT